Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2022 Filed Feb 17, 2022 11:01 UTC |
Decker Robert JController, CAO
|
Tax withholdingCommon Stock | 248 | $165.89 | $41,140.72 |
DisclosureSEC source: 0001225208-22-002378 · doc4.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 11:01 UTC |
Decker Robert JController, CAO
|
Exercise / conversionCommon Stock | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002378 · doc4.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:46 UTC |
Beckerle Mary CDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002576 · doc4.xml · derivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,355.318 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:46 UTC |
DAVIS D SCOTTDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002577 · doc4.xml · derivative · entry 1 DAVIS D SCOTT · CIK 0001227733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,196.532 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:46 UTC |
Davis IanDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002578 · doc4.xml · derivative · entry 1 Davis Ian · CIK 0001494009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,706.039 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:46 UTC |
Doudna Jennifer ADirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002579 · doc4.xml · derivative · entry 1 Doudna Jennifer A · CIK 0001739090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,132.765 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:46 UTC |
McClellan Mark B.Director
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002581 · doc4.xml · derivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,322.637 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:46 UTC |
Joly HubertDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002580 · doc4.xml · derivative · entry 1 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,613.814 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC |
MULCAHY ANNE MDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002582 · doc4.xml · derivative · entry 1 MULCAHY ANNE M · CIK 0001201725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,706.039 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002584 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,673 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC |
West NadjaDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002583 · doc4.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,326.845 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002586 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,733.9293 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002585 · doc4.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,205.367 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC |
WEINBERGER MARK ADirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002587 · doc4.xml · derivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,288.753 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:47 UTC |
PRINCE CHARLESDirector
|
GrantDeferred Share Units · Derivative | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002588 · doc4.xml · derivative · entry 1 PRINCE CHARLES · CIK 0001225179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,823.78 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2022 Filed Feb 19, 2022 00:15 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionPerformance Share Units · Derivative | 8,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002823 · doc4.xml · derivative · entry 5 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775 Underlying: Common Stock · 8,128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. F5 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. Read SEC document |
| February 15, 2022 Filed Feb 19, 2022 00:15 UTC |
Hait WilliamSee Remarks
|
Tax withholdingCommon Stock | 4,158 | $165.89 | $689,770.62 |
DisclosureSEC source: 0001225208-22-002823 · doc4.xml · nonDerivative · entry 2 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,236 F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 15, 2022 Filed Feb 19, 2022 00:15 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionCommon Stock | 8,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002823 · doc4.xml · nonDerivative · entry 1 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2022 Filed Feb 25, 2022 21:36 UTC |
Adamczyk DariusDirector
|
GrantDeferred Share Units · Derivative | 1,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003428 · doc4.xml · derivative · entry 1 Adamczyk Darius · CIK 0001605056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030 Underlying: Common Stock · 1,030 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionRestricted Share Units · Derivative | 3,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002211 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Tax withholdingCommon Stock | 1,190 | $168.85 | $200,931.50 |
DisclosureSEC source: 0001225208-22-002211 · doc4.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,233.001 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionCommon Stock | 3,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002211 · doc4.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,423.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 2,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002212 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,036 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 743 | $168.85 | $125,455.55 |
DisclosureSEC source: 0001225208-22-002212 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,636.0055 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 2,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002212 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,379.0055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Decker Robert JController, CAO
|
Exercise / conversionRestricted Share Units · Derivative | 866 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002213 · doc4.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 866 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Decker Robert JController, CAO
|
Tax withholdingCommon Stock | 263 | $168.85 | $44,407.55 |
DisclosureSEC source: 0001225208-22-002213 · doc4.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,818 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:02 UTC |
Decker Robert JController, CAO
|
Exercise / conversionCommon Stock | 866 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002213 · doc4.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionRestricted Share Units · Derivative | 2,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002214 · doc4.xml · derivative · entry 5 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,885 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Tax withholdingCommon Stock | 792 | $168.85 | $133,729.20 |
DisclosureSEC source: 0001225208-22-002214 · doc4.xml · nonDerivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,248.9545 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionCommon Stock | 2,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002214 · doc4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,040.9545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 2,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002216 · doc4.xml · derivative · entry 7 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Tax withholdingCommon Stock | 871 | $168.85 | $147,068.35 |
DisclosureSEC source: 0001225208-22-002216 · doc4.xml · nonDerivative · entry 4 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,857.882 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionCommon Stock | 2,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002216 · doc4.xml · nonDerivative · entry 3 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,728.882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionRestricted Share Units · Derivative | 3,759 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002215 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Tax withholdingCommon Stock | 1,520 | $168.85 | $256,652.00 |
DisclosureSEC source: 0001225208-22-002215 · doc4.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,824.2661 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionCommon Stock | 3,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002215 · doc4.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,344.2661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionRestricted Share Units · Derivative | 1,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002217 · doc4.xml · derivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,896 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Tax withholdingCommon Stock | 695 | $168.85 | $117,350.75 |
DisclosureSEC source: 0001225208-22-002217 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,623.8735 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionCommon Stock | 1,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002217 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,318.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002218 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 921 | $168.85 | $155,510.85 |
DisclosureSEC source: 0001225208-22-002218 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,384.204 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002218 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,305.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Broadhurst VanessaEVP, Global Corp Aff.
|
Exercise / conversionRestricted Share Units · Derivative | 2,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002219 · doc4.xml · derivative · entry 3 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,451 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Broadhurst VanessaEVP, Global Corp Aff.
|
Tax withholdingCommon Stock | 902 | $168.85 | $152,302.70 |
DisclosureSEC source: 0001225208-22-002219 · doc4.xml · nonDerivative · entry 2 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,035 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Broadhurst VanessaEVP, Global Corp Aff.
|
Exercise / conversionCommon Stock | 2,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002219 · doc4.xml · nonDerivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Mammen MathaiEVP, Pharm, R&D
|
Exercise / conversionRestricted Share Units · Derivative | 7,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002220 · doc4.xml · derivative · entry 3 Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Mammen MathaiEVP, Pharm, R&D
|
Tax withholdingCommon Stock | 2,335 | $168.85 | $394,264.75 |
DisclosureSEC source: 0001225208-22-002220 · doc4.xml · nonDerivative · entry 2 Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,560 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:03 UTC |
Mammen MathaiEVP, Pharm, R&D
|
Exercise / conversionCommon Stock | 7,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002220 · doc4.xml · nonDerivative · entry 1 Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 01:04 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionRestricted Share Units · Derivative | 7,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002221 · doc4.xml · derivative · entry 3 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.